Drug Type asPNA |
Synonyms- |
Target |
Mechanism miR-10b modulators(microRNA 10b modulators), miR-21 inhibitors(microRNA 21 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | 10 Feb 2023 |